Alpha Cognition Inc (ACOG) Cash Flow Statement

NASDAQ: ACOGOperating cash, capex, free cash flow and buybacks.

Where ACOG’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$20.4M
Capital expenditures
$293,489
2.9% of revenue
Free cash flow
−$20.7M
−202.3% margin
Returned to shareholders
—
Change in cash
$17.5M
cash at year-end $66.1M
Shares issued: $34.3MShares issued$34.3MOther financing: $4.8MOther financing$4.8MCash used in operations: $20.4MCash used in operations$20.4M · 52%Added to cash: $17.5MAdded to cash$17.5M · 45%Debt repayment, Capital expenditures: $1.2MOther uses$1.2M · 3%$39.1M
Cash from operations
−$20.4M
Capital expenditures
−$293,489
Net borrowing (repayment)
−$911,463
Shares issued
+$34.3M
Other financing
+$4.8M
Change in cash
$17.5M

Drawn to scale: where the cash came from and how it was used. Hover for values.

ACOG operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

ACOG cash flow trends, 2019–2025

Alpha Cognition Inc cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$47,3562019−$20.4M2025—
Capital expenditures$02019$293,4892025—
Free cash flow−$47,3562019−$20.7M2025—
Stock-based compensation$708,5662020$4.9M2025+47.4%/yr
Dividends paid$02020$02023—

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ACOG cash flow by activity

OperatingInvestingFinancingChange in cash

ACOG net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

ACOG cash flow statement

Alpha Cognition Inc annual cash flow statement
2025202420232022202120202019
Operating activities
Net income−$20.7M−$14.6M−$13.8M−$16.3M−$24.9M−$7.4M−$118,593
Depreciation & amortization$58,572$81,220$84,479$122,168$114,546$103,994—
Stock-based compensation$4.9M$979,799$2.4M$2.3M$2.3M$708,566—
Change in working capital−$4.6M−$241,679−$1.6M$3.7M−$368,273−$416,036$15,172
Other non-cash items−$72,706$6.1M$4.1M−$2.2M$10.3M$45,975$56,065
Cash from operating activities−$20.4M−$7.8M−$8.7M−$12.4M−$12.6M−$6.9M−$47,356
Investing activities
Capital expenditures−$293,489−$26,701−$5−$6,552−$81,141−$11,795$0
Investments (net)—−$26,701$0−$4,876$459,375−$9,238—
Acquisitions & other investing$0$26,701—$4,876$207,232$9,238—
Cash from investing activities−$293,489−$26,701—−$6,552$585,466−$11,795—
Financing activities
Dividends paid——$0$0$0$0—
Net borrowing (repayment)−$911,463$4.2M−$55,000$0$0——
Shares issued$34.3M$56.5M$9.2M$0$13.7M$1.9M$0
Other financing$4.8M−$5.9M−$1.0M$33,302$5.3M$5.6M$590,172
Cash from financing activities$38.2M$54.9M$8.2M$33,302$19.0M$7.5M$590,172
Summary
Net change in cash$17.5M$47.1M−$589,123−$12.4M$6.9M$547,579$544,186
Cash at end of period$66.1M$48.6M$1.5M$2.8M$14.4M$7.6M$875,547
Free cash flow−$20.7M−$7.8M−$8.7M−$12.4M−$12.7M−$7.0M−$47,356
Free cash flow margin−202.3%——————
Capex / revenue2.9%——————

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

ACOG cash generation

In fiscal 2025 (ended December 31, 2025), Alpha Cognition generated -$20.4 million of cash from operations and spent $0.3 million on capital expenditures, leaving free cash flow of -$20.7 million, −202.3% of revenue. Cash and equivalents rose by $17.5 million over the year.

Related: ACOG income statement, ACOG balance sheet. See the ACOG stock overview for the latest quote and news.

ACOG cash flow FAQ

What is Alpha Cognition's free cash flow?

Alpha Cognition's free cash flow was -$20.7 million in fiscal 2025: -$20.4 million of operating cash flow minus $0.3 million of capital expenditures It was -$7.8 million a year earlier..

How much cash does Alpha Cognition generate from operations?

Alpha Cognition generated -$20.4 million of cash from operating activities in fiscal 2025.

How much does Alpha Cognition spend on capital expenditures?

Alpha Cognition spent $0.3 million on capital expenditures in fiscal 2025, 2.9% of revenue, compared with $0.0 million the year before.

Biotechnology: cash flow